Gohibic For SARS-CoV-2-Induced ARDS Among Eight New Drugs To Win EMA Nod

 
• By Neena Brizmohun

Patients in the ICU continue to die from SARS-CoV-2-induced acute respiratory distress syndrome, says InflaRx, which is one of companies whose product the European Medicines Agency today announced should be approved for marketing in the EU.

Diagnosis Acute respiratory distress syndrome ARDS and stethoscope
A new treatment for SARS-CoV-2-induced ARDS could be approved for use in the EU soon (Shutterstock)

More from EU CHMP

More from Europe